Gallbladder Cancer Clinical Trials in Georgia

Georgia's Online Cancer Information Center


back

Gallbladder Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Gallbladder Cancer
Cancer Type = Gallbladder Cancer
NCI ID Cancer Type Trial Name
There are currently 5 active Gallbladder Cancer clinical trials in Georgia.
NCI ID Cancer Type Trial Name
1.
A Beta-only IL-2 ImmunoTherapY Study
Cancer Type
Bile Duct Cancer, Bladder Cancer, Cervical Cancer, Colon/Rectal Cancer, Gallbladder Cancer, Melanoma, Ovarian Cancer, Sarcoma, Stomach/ Gastric Cancer
NCT ID
NCT05086692
Protocol IDs
MDNA11-01
NCI-2022-02678
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
2.
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) (AB02)
Cancer Type
Bile Duct Cancer, Gallbladder Cancer, Liver Cancer / Hepatoblastoma
NCT ID
NCT07221253
Protocol IDs
D702NC00001
Treatment Sites (4)
Northwest Georgia Oncology Centers - Cobb Hospital (Hiram)
Hiram
Kristine Parker, RN Clinical Research Director
770-281-5131
Northwest Georgia Oncology Centers - Douglasville
Douglasville
Kristine Parker, RN Clinical Research Director
770-281-5101
Northwest Georgia Oncology Centers - Tanner Medical Center Villa Rica
Carrollton
Kristine Parker, RN Clinical Research Director
770-281-5101
Northwest Georgia Oncology Centers (NGOC) - Cobb Hospital (Marietta)
Marietta
Kristine Parker, RN Clinical Research Director
770-281-5101
3.
NCORP Trial
Comparison of Chemotherapy before and after Surgery versus after Surgery Alone for the Treatment of Gallbladder Cancer, OPT-IN Trial
Cancer Type
Gallbladder Cancer, Unknown Primary
NCT ID
NCT04559139
Protocol IDs
EA2197
EA2197
NCI-2020-05162
4.
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Cancer Type
Bile Duct Cancer, Gallbladder Cancer
NCT ID
NCT06282575
Protocol IDs
JZP598-302
NCI-2024-03767
2023-508219-21-00
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
5.
Study of Chemotherapy, with or without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
Cancer Type
Gallbladder Cancer
NCT ID
NCT05564403
Protocol IDs
EAY191-A6
EAY191-A6
NCI-2022-07833
Treatment Sites (1)
City of Hope Atlanta
Newnan
Brian Wortz, PharmD, ACRP-CP
770-400-6169
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Find Cancer Care

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

 

Georgia CORE reduces the burden of cancer in our state through research, education, and advocacy.